BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3582449)

  • 1. Hyperfractionated, accelerated radiotherapy and concurrent chemotherapy in locally advanced bladder cancer.
    Jakse G; Fritsch E; Frommhold H
    Eur Urol; 1987; 13(1-2):22-5. PubMed ID: 3582449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent adriamycin and radiotherapy in locally advanced bladder cancer.
    Jakse G; Fritsch E; Frommhold H
    Br J Urol; 1989 Jan; 63(1):64-7. PubMed ID: 2920262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of locally advanced bladder cancer by hyperfractionated radiotherapy and chemotherapy.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1988; 260():431-6. PubMed ID: 3129732
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy and chemotherapy in locally advanced bladder cancer.
    Jakse G; Frommhold H
    Eur Urol; 1988; 14 Suppl 1():45. PubMed ID: 3181245
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
    Jakse G; Frommhold H; zur Nedden D
    Cancer; 1985 Apr; 55(8):1659-64. PubMed ID: 4038912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
    Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined treatment of invasive bladder cancer by intra-arterial infusion chemotherapy of cisplatin with or without other anticancer agents and concurrent radiotherapy--initial response and side effects].
    Eiro I; Kanetsuki I; Takeshita T; Yano T; Uchiyama N; Onohara S; Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun; 52(6):793-8. PubMed ID: 1641310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y; Yoshida K
    Hinyokika Kiyo; 1999 Feb; 45(2):149-53. PubMed ID: 10212791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
    Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma.
    Mokarim A; Uetani M; Hayashi N; Sakamoto I; Minami K; Ogawa Y; Ochi M; Matsuoka Y; Hayashi K; Nomata K
    Cancer; 1997 Nov; 80(9):1776-85. PubMed ID: 9351547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil: a phase I study.
    Danesi DT; Arcangeli G; Cruciani E; Mecozzi A; Saracino B; Giacobini S; Pannunzio E; Biggio A; Orefici F
    Cancer; 1997 Oct; 80(8):1464-71. PubMed ID: 9338471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
    Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
    Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases.
    Valente R; Marini F; Signori GB; Martino F
    Arch Esp Urol; 1989; 42(1):87-9. PubMed ID: 2712609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B; Félix-Faure C; Davin JL; Berger C; Vincent P; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined cisplatin and radiation therapy in patients with invasive bladder cancer].
    Mori Y; Arima M; Shimada K; Shima H; Terakawa T; Yabumoto H; Tsujimoto S; Hosokawa S; Ogino T; Fujisue H
    Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1345-53. PubMed ID: 3325677
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G
    Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.